CANGRELOR for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 81 adverse event reports in the FDA FAERS database where CANGRELOR was used for Off label use.
Most Reported Side Effects for CANGRELOR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 144 | 44.6% | 25 | 9 |
| Vascular stent thrombosis | 29 | 9.0% | 4 | 1 |
| Drug ineffective | 26 | 8.1% | 3 | 13 |
| Haemorrhage | 22 | 6.8% | 6 | 5 |
| Death | 19 | 5.9% | 19 | 0 |
| No adverse event | 19 | 5.9% | 0 | 0 |
| Inappropriate schedule of product administration | 18 | 5.6% | 5 | 3 |
| Cardiac arrest | 15 | 4.6% | 8 | 0 |
| Cardiogenic shock | 14 | 4.3% | 11 | 3 |
| Gastrointestinal haemorrhage | 12 | 3.7% | 2 | 6 |
| Intentional product use issue | 11 | 3.4% | 1 | 1 |
| Drug ineffective for unapproved indication | 9 | 2.8% | 2 | 0 |
| Dyspnoea | 9 | 2.8% | 1 | 0 |
| Haemorrhage intracranial | 9 | 2.8% | 3 | 2 |
| Vascular access site haemorrhage | 9 | 2.8% | 3 | 1 |
Other Indications for CANGRELOR
Percutaneous coronary intervention (94)
Product used for unknown indication (83)
Antiplatelet therapy (41)
Acute myocardial infarction (17)
Stent placement (15)
Thrombosis prophylaxis (12)
Anticoagulant therapy (10)
Coronary artery bypass (6)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)